Your Basket's Financial Footprint
Summary of market cap composition for the Pharma basket.
- Large-cap dominance suggests generally lower volatility and more stable returns, closely tracking broad market healthcare performance.
- Suitable as a core, long-term holding for diversified portfolios rather than a speculative or high-conviction growth position.
- Expect steady, incremental appreciation over time; less likely to deliver explosive short-term gains.
JNJ: $462.30B
PFE: $141.29B
MRNA: $10.74B
- Other
About This Group of Stocks
Our Expert Thinking
Pharmaceutical companies offer a unique combination of stability and growth potential. With consistent demand for healthcare and ongoing innovation in treatments, this industry is projected to grow at 7% annually, reaching $1.9 trillion by 2027.
What You Need to Know
These pharma stocks represent companies focused on developing life-improving and life-saving medications. The healthcare sector tends to be more resilient during economic downturns, as medical needs remain constant regardless of market conditions.
Why These Stocks
This collection includes established pharmaceutical giants alongside innovative biotech companies. These stocks were selected based on their market leadership, research capabilities, and potential for growth through new treatments and medications.
Why You'll Want to Watch These Stocks
Healthcare's Golden Opportunity
The pharma industry is expected to reach $1.9 trillion by 2027. Getting in now means you could benefit from this massive growth trajectory as companies develop new treatments.
Innovation Worth Watching
Companies like Moderna and Novavax showed how pharmaceutical breakthroughs can lead to extraordinary gains. These stocks represent the future of healthcare innovation.
Recession-Resistant Potential
Healthcare needs remain constant regardless of economic conditions, making pharma stocks potentially more stable during market downturns while still offering growth.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Dow Record Rally: What's Next for Value Stocks?
The Dow Jones Industrial Average reached a historic high, closing above 48,000, fueled by the end of a government shutdown and a market rotation into value stocks. This shift suggests an investment opportunity in the outperforming healthcare and financial sectors, which are leading the charge.
LNG Infrastructure Stocks: Mozambique Boom 2025
TotalEnergies is set to resume its $20 billion liquefied natural gas (LNG) project in Mozambique, a major development for the global energy market. This creates an investment opportunity in companies that provide essential infrastructure, transportation, and security services for large-scale energy projects.
Auto Stocks: Recall Risks May Shift Market Share
Toyota has recalled over 126,000 vehicles due to an engine stall risk, creating a potential loss of consumer confidence. This situation presents an opportunity for competing automakers and their parts suppliers to capture market share from a key rival.